W, F168-B dyyzer Reprocessing apparatus orci application

In contentus est magazine reperport:
- Extracted ex Acta Biomedicaling Engineering, MMIX June MMIX
Yang Lichuan, Zheng Yujun, Deng Zhengxu, Fu Ping, Chen Lin

Observa in orci applicationem effectus in W-F168-b dyyzer reuse apparatus produci by Chengdu Weisheng Biological Materials Company, intelligere suum impulsum in totalis cellula volumine (TCV) de dialyzer et dialysis adaequabit, et aestimare dialysis effectus. Subjects qui occurrit inclusion criteria passim dividitur in duo coetus. In dialyzers in experimentalem coetus et imperium coetus sunt reddi cum w-f168-b et renatron II (produci per MinTech in Civitatibus Foederatis Americae), respective. Test in TCV de dialyzer ante et post reuse, calculate ad Urea alvi rate de subiectis divisa per distribution volumine (KT / V, ubi K est Urea Clearance Rate, T est Dialysis tempus, et V est distributio Dialysis in Cultura. Eventus expresserunt quod medium ± vexillum deviation, usura a T-test cum coetus consilio et resolvitur per SPSS 13,0 Statistical Software Package. Differentia in TCV inter experimentalem coetus et imperium coetus ante et post Reuse erat 5.5 ± 4,15, 4.5 ± 2.56 et P0.05, respective; Et KT / V values ​​fuerunt 1.25 ± 0.26, 1.24 ± 0,24, et P0.05, respective et T-test eventus ostendit non statistical differentia. Nulla bacterial vel fungal augmentum observata in sanguine cultura. In experimentum eventus ostendere quod non est significant differentia in impulsum duplici generis dialyzer reuse machinas in dialyzer perficientur et impulsum de reused dialyzer in dialysis adaequantibus, quae potest consequi bonum dialysis qualitas.

[Nota] Author s Unit: Department of Nephrology, West Sinis hospitalis, Sichuan University.

Previous Post: Praesidem, etc of Taiwan Lienchang Group venit ad Weilisheng pro Electronic Accessories Business Consultationes.
Next Post: Praesidem, etc Taiwan Lienchang Group, ad Weilisheng ad electronic accessiones Business consultationes.